Stay updated on LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Sign up to get notified when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.

Latest updates to the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1. These are administrative UI/text updates and do not alter study data or participation information.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding lapse notice informing users that operations may be affected and directing them to cc.nih.gov for current updates; the NIH Clinical Center remains open. Footer revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI updates include showing the glossary by default, updating the label to 'Last Update Submitted that Met QC Criteria', adding 'No FEAR Act Data' text, and updating the revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedThe update removes extensive IPD sharing information and related policy sections from the Study Details page; core study information such as eligibility, interventions, and locations remains available. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference20%

- Check64 days agoChange DetectedMaryland is added under Locations and Maryland Locations is removed, with the page revision updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no substantive changes to the study details are visible.SummaryDifference0.1%

Stay in the know with updates to LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.